Intelligence Platform
Patents
Browse 89 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 7772387
Oligonucleotides comprising a modified or non-natural nucleobase
granted patentUS 7638300
In vivo incorporation of unnatural amino acids
granted patentUS 7632932
Oligonucleotides comprising a ligand tethered to a modified or non-natural nucleobase
granted patentUS 7579451
Oligonucleotides comprising a modified or non-natural nucleobase
granted patentUS 7368275
In vivo incorporation of unnatural amino acids
granted patentUS 7045337
In vivo incorporation of unnatural amino acids
expired patentUS 6638543
Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and
expired patentUS 6458766
Halovir, an antiviral marine natural product, and derivatives thereof
expired patentUS 6432395
Cleaning composition containing naturally-derived components
expired patentUS 6433144
Compositions of highly-purified natural mixtures of type I Interferon derived from leukocy
expired patentUS 6375946
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero
expired patentUS 6350589
Compositions of highly-purified natural mixtures of type I interferon derived from leukocy
expired patentUS 6262244
DNA and amino acid sequence specific for natural killer cells
expired patentUS 6245563
Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxi
expired patentUS 6143304
Enhanced yield of podophyllotoxin from natural products through in situ conversion methods
expired patentUS 6071509
Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero
expired patentUS 6069146
Halimide, a cytotoxic marine natural product, and derivatives thereof
expired